Proteoglycogen is the end product in the process of glycogen biogenesis. We have purified rabbit muscle proteoglycogen and studied the glucosyltransferase reactions catalyzed by its protein moiety, glycogenin, free or bound to the polysaccharide. The purification strategy involved dissolution of proteoglycogen and cosedimenting membrane vesicles in a Triton X-114/Triton X-45 mixture followed by partition in the aqueous phase, potassium iodide precipitation of accompanying proteins, and washing by high-speed centrifugation. Glycogenin or a proteoglycogen species of an average molecular mass of 200 kDa was isolated by ion-exchange chromatography after the purified proteoglycogen had been subjected to long or short amylolytic digestion, respectively. Besides autoglucosylation from UDPglucose, glycogenin was capable of autogalactosylation from UDP-galactose. The autoglucosylation reaction was not inhibited by the simultaneous glucosylation of the exogenous acceptors N-(maltosyl-a-l-4-(l-deoxiglucitol) )-peptide or n-dodecyl-B-D-maltoside. The polysaccharidebound glycogenin species of 200 kDa showed to be active for the glucosylation of exogenous acceptor and represented the isolated proteoglycogen of higher size having glucosyl transferase activity. This is the first description of the isolation of native proteoglycogen and a proteoglycogen species having glucosyltransferase activity.
Introduction
Proteoglycogen is the name given to protein-bound glycogen (Aon and Curtino, 1984; Miozzo et al., 1989) . The glycoconjugate is constituted by the polysaccharide linked to a protein called glycogenin (Rodriguez and Fliesler, 1988) , and represents the end product of the de novo biosynthesis of glycogen. This process begins with the autoglucosylation of glycogenin (Lomako et al., 1988; Pitcher et al, 1988) to produce the primer for further glucan polymerization carried out by glycogen synthase (EC 2.4.1.11) (Smythe and Cohen, 1991) . A third enzyme, branching enzyme (EC 2.4.1.18), participates in giving the final shape to the polysaccharide. Krisman and Barengo (1975) had first postulated a protein primer for the initiation of glycogen polymerization. Glycogenin can glucosylate exogenous acceptors besides autoglucosylation. These acceptors are maltose (Cao et al., 1995) and alkyl maltosides, as />-nitrophenyl-a-maltoside (Lomako et al., 1990) and n-dodecyl-(J-r> maltoside . No detailed study on the simultaneous autoglucosylation and glucosylation of any of the exogenous acceptors has so far been reported.
The present work describes for the first time the purification of skeletal muscle proteoglycogen and its capability for the glucosylation of exogenous acceptor, after the polysaccharide moiety is reduced in size, at least to give a 200 kDa proteoglycogen species . We also describe the isolation of PG-200 and glycogenin, and show that (1) autoglucosylation of glycogenin is not inhibited by the simultaneous glucosylation of the substrates maltosyl-glycopeptide or dodecyl-fimaltoside, and (2) besides autoglucosylation glycogenin is capable of autogalactosylation.
Results

Purification of proteoglycogen
A New Zealand White rabbit was sacrificed and the skeletal muscle removed and chilled in ice as described previously (Cohen, 1983) . Unless otherwise indicated, all the subsequent steps were performed at 1-5°C.
Step 1. Cosedimentation of proteoglycogen and membrane vesicles. The muscle was ground in a meat mincer and the minced muscle (400 g) was homogenized in a Waring blender for 1 min with 2 volumes of 4 mM EDTA pH 7.0, 0.5 raM PMSF, 2 mM benzamidine, and 0.1% P-mercaptoethanol. The homogenate was centrifuged at 4800 x g for 40 min and the supernatant (muscle extract) was decanted through glass wool and centrifuged at 75,000 x g for 1 h. A loose membrane vesicles layer, which covered the translucent clear pellet at the bottom of the tubes, was discarded by keeping the tubes inverted after the supernatant was poured off. The pellets were kept overnight (or stored for at least three months) at -20°C.
Step 2. Solubilization in detergent having phase separation properties. The separation of residual membrane vesicles cosedimenting with proteoglycogen was accomplished by disruption of the membranes with a detergent mixture that forms a homogeneous solution below a critical temperature (cloudy point), above which it undergoes phase separation from solution (Ganong and Delmore, 1991) . The pellets were dissolved in 1.1% of a mixture of Triton X-114:Triton X-45 (86.5:13.5) containing 10 mM Tris-HCl buffer pH 7.5, 0.15 M NaCl, 4 mM dithiothreitol, 0.5 mM PMSF, and 1 mM benzamidine. A total volume of 48 ml of the detergent solution was used to dissolve the proteoglycogen pellets. The temperature of the solution was raised to 13-14°C to allow phase separation. The cloudy solution was immediately centrifuged at 1000 x g for 3 min in the cold room (5°C), after which the tubes were kept standing for 5 min in the cold room to allow clarifying of the separated phases. The upper aqueous phase was collected and cooled in an ice-water bath.
Step 3. Potassium iodide precipitation of accompanying proteins. After partition, the proteoglycogen collected from the aqueous phase by high speed centrifugation (see step 4) still contained membrane proteins and glycogen synthase that could not be entirely removed by the final washing step. The elimination of these contaminants was achieved by precipitating the proteins in the upper aqueous phase with 3.6 M potassium iodide before sedimentation of proteoglycogen at 235000 g (Figure 1 ). After standing for 15 min in the ice bath the precipitated protein was sedimented at 8700 g for 10 min.
Step 4. High speed sedimentation and washing of proteoglycogen. The 8700 x g supernatant was diluted to 2.0 M KI with 0.1 M Tris-HCl buffer pH 7.5, made 0.2% in Triton X-100 and centrifuged at 235,000 x g for 90 min. The supernatant was discarded, the walls of the tubes were rinsed with water and the proteoglycogen pellets dissolved in a volume equal to the discarded supernatant of 0.1 M Tris-HCl buffer pH 7.5 containing 0.2% Triton X-100, 2 mM dithiothreitol, 0.25 mM PMSF, and 1 mM benzamidine. After centrifugation at 235,000 x g for 90 min, the washed proteoglycogen pellets were dissolved with a total volume of 3.6 ml of 20 mM Tris-acetate buffer pH 7.5 and Table I .
Isolation of glycogenin
Glycogenin was released from the purified proteoglycogen by amylolytic digestion of its polysaccharide moiety. The isolation of glycogenin from the amylolytic enzymes and reaction products was carried out by passage through a small column of Q Sepharose (see Materials and methods). The recovery was 93% of the glycogenin present in the amylolyzed proteoglycogen solution, as judged by SDS-PAGE and autoglucosyltransferase activity (results not shown).
Glucosyltransferase activity of the isolated glycogenin Autoglucosylation. As originally described (Lomako et al., 1988; Pitcher et al., 1988) , the isolated glycogenin autoincorporated [
14 C]glucose after incubation with UDP-14 C-glucose in the presence of Mn 2+ ; the requirement for Mn 2+ , which was also shown for the autoglucosylation of M-glycogenin (Goldraij and Curtino, 1996) , had been previously described for the elongation of a glucoproteic precursor of starch biosynthesis (Lavintman et al., 1974) . The labeled product was identified by SDS-PAGE and autoradiography ( Figure 2 ). The autoglucosylation rate was dependent on the concentration of enzyme (Figure 3) .
Glucosylation of exogenous acceptors. In order to study the reaction responsible for the polysaccharide-glycogenin linkage formation, the nonapeptide SISIYSYLP, which contains the amino acid sequence of glycogenin around the tyrosine-194 implicated in the linkage of a glucosyl residue (Smythe et al., 1988) , was tested as acceptor substrate. No activity was found after incubation of the peptide with UDP-[ 14 C]glucose and different preparations from muscle, retina, and brain or the isolated glycogenin as source of enzyme. Glycosylation of the nonapeptide with lactose by reductive amination, in order to increase the solubility of the peptide, had no effect on its acceptor activity. It has been described previously that alkylmaltosides (p-nitrophenyl maltoside and dodecyl maltoside) are exogenous substrates for glycogenin activity, incorporating a glucose unit a-1,4 linked to the nonreducing end of maltose (Lomako et aL, 1990; Manzella et al., 1994) . The addition of a maltose residue in the nonapeptide by reductive amination with maltotriose resulted in an acceptor substrate for glycogenin (Table II) . The incorporation of a [
14 C]glucose unit into the maltosyl moiety of the glycopeptide, after incubation of glycogenin with UDP-[ 14 C]glucose and N-(maltosyl-a-l-4-(ldeoxyglucitol))-peptide (MDGP), was deduced from (1) the complete inactivity of the intact and N-lactosylated peptides as acceptor substrates; (2) the mobility in TLC of die labeled reaction product using glucosylated, maltosylated, maltotriosylated, and maltotetraosylated peptides as standards; (3) the stability of the labeled reaction product to fj-elimination (indicative that [
14 C]glucose was not incorporated into a p-eliminable serine residue); (4) the absence of [ 14 C]glucosylated tyrosine residues in the reaction product; (5) the complete release of [ 14 C]glucose (identified by TLC) upon digestion with amyloglucosidase (results not shown).
Autoglucosylation during the glucosylation of exogenous acceptor.
A procedure that combines the precipitation of glycogenin with trichloroacetic acid and the isolation of the glycopeptide by passing the trichloroacetic acid soluble fraction through a C 18 cartridge, was used to study the simultaneous glucosylations of MDGP and glycogenin. Table II shows that a substantial portion of the 14 C-glucosylated glycopeptide coprecipitated with glycogenin, a behavior also described when DBM was used as substrate (Manzella et al., 1995) . Extraction with methanol of the 14 C-glucosylated glycopeptide from the TCA-insoluble residue allowed the simultaneous measurement of glycogenin autoglucosylation and glucosylation of the exogenous acceptor (Table II) . As expected from the absolute requirement of manganese ions for glycogenin activity, the absence of the cation prevents glycopeptide glucosylation. Figure 4 shows the time course for both reactions. The glucosylation of the glycopeptide was independent of the degree of autoglucosylation of glycogenin; the reaction with MDGP continued even when the acceptor capacity for autoglucosylation was exhausted. Moreover, autoglucosylation was unaffected by the simultaneous glucosylation of MDGP (Table II) . Similar results were obtained with the alkylmaltoside DBM. The formation of [ 14 C]glucosylated DBM, previously described and characterized by Manzella et al. (1994 Manzella et al. ( , 1995 , was verified by TLC as described previously (Goldraij and Curtino, 1996; result not shown). As with the glycopeptide, the glucosylation of DBM continued after glycogenin autoglucosylation reached plateau ( Figure 5 ). Even at near saturating concentration of DBM [0.16 mM, the CMC of this detergent (De Grip and Bovee-Geurts, 1979) ], the autoglucosylation reaction was not inhibited (Figure 6 ). Both, autoglucosylation and glucosylation of DBM were inhibited by UDP (Figure 7 ). Donor substrates. The ability of glycogenin to autoincorporate xylose from UDP-xylose has been described (Meezan et al, 1994) . Table III and Figure 8 show that the enzyme can also use UDP-galactose as glycosyl donor. The stability to a-amylase and amyloglucosidase treatments of the glycogenin glycosylated from UDP-galactose (Table TV) was consistent with the galactosylation of glycogenin. UDP-N-acetylglucosamine and GDP-mannose proved to be inactive as substrates.
Proteoglycogen as a giucosyltransferase
The results showing that exogenous acceptors were glucosylated independently of glycogenin having reached a maximal degree of autoglucosylation (Figures 4, 5) led us to consider that the reaction with exogenous acceptor might occur with the whole proteoglycogen molecule acting as a glucosyltransferase. This assumption proved to be correct, not for the intact molecule but for proteoglycogen that was reduced in size by a short treatment with a-amylase. The mild digestion, which allowed the proteopolysaccharide to move through the 3% and 5% stacking gels and to enter the upper zone of the resolving gel without releasing polysaccharide-free glycogenin, resulted in expression of giucosyltransferase activity toward DBM. The activity was comparable to that of polysaccharide-free glycogenin released from the same amount of proteoglycogen by a longer a-amylase treatment ( Figure 9 ). As expected, the activity of proteoglycogen has an absolute requirement for manganese ions (result not shown).
Isolation of PG-200
In order to identify and isolate the active proteoglycogen species produced by the mild amylolitic digestion, the amylolyzed 0.7 1.4 2.1 Glycogenin (u\g) 2.8 
Discussion
This study is the first report on the isolation of proteoglycogen without denaturing its glycogenin moiety. The purification was facilitated by the utilization of detergent, which disrupts the membrane vesicles that had been impossible to separate from proteoglycogen by differential or isopicnic centrifugation. Selection of the Triton X-114ATriton X-45 mixture was decided by their rapid and near complete removal, together with the bulk of solubilized hydrophobic membrane constituents. Furthermore, in the proportions used, the phase separation occurred at a lower temperature than Triton X-114 alone (Bordier, 1981) , and diminished the risk of polysaccharide degradation by endogenous amylolytic activity. This would result in making proteoglycogen nonsedimentable by high speed centrifugation. The proteins that partition in the upper aqueous phase were eliminated by salting out in 3.6 M potassium iodide, a chaotropic agent that might allow to the dissociation of glycogen synthase from glycogen ( Figure 1 ). When the bulk of membrane vesicles that cosedimented with proteoglycogen was not poured off with the supernatant before dissolution in the detergent mixture, a protease activity contaminated the proteoglycogen preparation causing cleavage of glycogenin to a Mr of 31,000. The truncated glycogenin was active for autoglucosylation and its amino terminal residue was blocked as in the native glycogenin (results not shown), which would indicate that the proteolytic cleavage had occurred at the carboxyl terminus. A protease activity was also reported as a contaminant of recombinant glycogenin (Alonso et al., 1995) . The purified proteoglycogen was free of noncovalent bound protein as concluded from the analysis in SDS-PAGE using a sensitive staining procedure (see Materials and methods) and gels heavily loaded (Figure 1 ). From the quantitative data of the purification (Table I) it is inferred that glycogen-bound glycogenin constitutes 0.05% of the total protein in the muscle extract We had described before the isolation of proteoglycogen containing denatured glycogenin, which precipitated from solution when released from the polysaccharide moiety (Goldraij et al., 1993) . Glycogenin was released from the purified proteoglycogen by amylolytic treatment and isolated by passage through a Q-Sepharose column. The entire procedure for the purification of proteoglycogen and isolation of glycogenin rendered 3 mg of glycogenin from 400 g of rabbit muscle. The glycogenin solutions could be stored at -20°C (with the addition of 0.24 M sucrose) for at least 6 months, or at 4°C (with the addition of 0.2% sodium azide) for at least 1 month, without appreciable loss of activity. Our glycogenin preparation autoglucosylated with a kinetic that suggested an intermolecular mechanism of reaction (Figure 3 ), in agreement with results in which a recombinant enzyme preparation was used (Alonso et al., 1995) .
Glycogenin can act as a xylosyltransferase, the autoxylo-10 20 30 UDP sylation occurring at about one tenth the rate of autoglucosylation (see Meezan et al., 1994, Figure 3) . We show that glycogenin can also autogalactosylate (Table El, Figure 8 ). The rate of galactose incorporation was about one-seventeenth of the rate of glucosylation.
It has been described that glycogenin was able to glucosylate exogenous acceptors. We coupled maltotriose to the amino terminal group of a peptide resulting in a maltosyl residue bound to deoxiglucitolpeptide, which was an acceptor substrate for glycogenin. As shown in Table II , autoglucosylation was not inhibited by the simultaneous glucosylation of the malto- Table HI. syl-glycopeptide. No inhibition of autoglucosylation was seen either when DBM was glucosylated, even at near saturating concentration of the acceptor (Figure 6 ). It should be noticed that unless the conditions of the assay are selected in order to avoid a high glucosylation of DBM, the high production of UDP in the reaction will inhibit autoglucosylation by competition with UDP-glucose (Figure 7) . This, together with the very low concentration of sugar nucleotide utilized, might be the cause of the inhibition reported before for the autoglucosylation of glycogenin in the presence of DBM (Manzella et al., 1995) . Our results on the simultaneous and independent autoglucosylation and glucosylation of exogenous acceptors might indicate that glycogenin has two catalytic sites, one for glucosylation of its tyrosine linked acceptor and the other for the glucosylation of the exogenous maltosyl acceptors. An alternate explanation might be that glycogenin has a much lower K,,, for itself than for the exogenous acceptors, or that autoglucosylation is a vectorial process in which the enzyme-self acceptor complex does not dissociate until the acceptor reaches its highest degree of autoglucosylation. However, neither inhibition of autoglucosylation occurred at near saturating concentration of DBM (Figure 6 ), nor a lag was observed in the time course of glucosylation of DBM (Figure 5 ), as would be . Glucosyltransferase activity of proteoglycogen. Protcoglycogen, untreated (B) or subjected to short (A) and long (C) amylolytic digestion, was incubated with 0.2 mM DBM and 28 uM UDP-[ 14 C]glucose for 10 min. Aliquots corresponding to 110 p.g of glycogen were subjected to SDS-PAGE (silver stain) in a 10% acrylamide resolving gel with a 3% (a) and 5% (b) stacking gels, and analyzed for radioactivity incorporated into DBM (lower figures). The arrow points to glycogenin.
expected if autoglucosylation was a vectorial process. Further studies will be required to ascertain whether the apparent site for the independent glucosylation of exogenous acceptors is an extra-catalytic site in the glycogenin molecule.
We also showed that the exogenous acceptors were glucosylated independently of glycogenin having reached its maximal degree of autoglucosylation (Figures 4, 5) . This leads us to consider the possibility that polysaccharide linked to the tyrosine residue of glycogenin might not affect the glucosylation of exogenous acceptors. This was confirmed after reducing the size of the polysaccharide moiety of proteoglycogen ( Figure  9 ). The upper size of the polysaccharide moiety that allows the expression of the glucosyltransferase activity of glycogenin is, at least, that giving the whole isolated molecule an average mass of 200 kDa, as determined by gel filtration. Whether this activity has any functional role and why the higher proteoglycogen species are inactive, remain open questions.
Materials and methods
Materials
UDP-[
l4 C]glucose (300 mCi/mmol) was purchased from Instituto de Investigaciones Bioqufmicas Fundaci6n Campomar (Buenos Aires, Argentina).
3 H]galactose (15 Ci/mmol) was obtained from American Radiolabeled Chemicals. Leupeptin, pepstatin, PMSF, BAPNA, TLCK, APMSF, benzamidine, p-mercaptoethanol, Triton X-114, Triton X-100, Triton X-45, Q Sepharose (fast flow), maltotriose, lactose, UDP-glucose, Mes, bovine serum albumin, and DBM were from Sigma. Amyloglucosidase from Aspergillus niger, a-amylase from Bacillus subtilis and D-glucose test kit (hexokinasc/glucose-6-phosphate dehydrogenase containing reagent) were from Boehringcr Mannheim and C 18 cartridges from Waters. The nonapeptide SISIYSYLP was purchased from Neosystem (Strasburg, France).
Release of glycogenin and PG-200 from proteoglycogen
Each of the amylolytic enzymes used were subjected to FPLC on a MonoQ column equilibrated with 20 mM Tris-acetate buffer pH 7.5. Protein was eluted with a linear gradient of 0.5 M Na 3 PO 4 in 20 mM Tris-acetate buffer pH 7.5. The protein peak of amyloglucosidase eluted with 0.45 M Na 3 PO4 and the a-amylase peak eluted with 0.07 M Na 3 PO4 were used for the amylolytic treatments.
For the release of glycogenin, proteoglycogen (3.3%) in 20 mM Tris-acetate pH 7.5 containing 1 mM CaCl 2 , 0.2% sodium azide, 0.016% BAPNA, 0.4 mM TLCK, and 0.1 mM each of leupeptin, pepstatin, and APMSF, was amylolyzed with 10 u.g/ml each of amyloglucosidase and a-amylase for 20 h at 25°C.
For the release of PG-200, the polysaccharide moiety of proteoglycogen was digested as described above, except for the omission of amyloglucosidase and BAPNA, the addition of 10 mM MES pH 7.0, and the reductions of proteoglycogen concentration to 1.6%, Tris-acetate buffer to 3 mM, CaCl 2 to 0.3 mM, sodium azide to 0.06%, TLCK to 0.12 mM, the other protease inhibitors to 0.03 mM each, a-amylase to 3 u.g/ml, and of incubation time to 10 min.
Isolation of glycogenin and PG-200
For the isolation of glycogenin, the amylolyzed proteoglycogen (up to 2 ml) was passed through a small column (0.2 ml) of Q Sepharose equilibrated with 20 mM Tris-acetate buffer pH 7.5 (Tns buffer). After elution of a-amylase with 1.6 ml of Tris buffer containing 60 mM NaCl, glycogenin was eluted with 0.5 ml of Tris buffer containing 250 mM NaCl. The glycogenin solution was supplemented with 0.2% sodium azide or 0.24 M sucrose and stored at 4 C C or -20°C, respectively.
For the isolation of PG-200, the amylolyzed mixture (up to 0.85 ml) was cooled in an ice-water bam, made 60 mM in NaCl and immediately passed through the Q Sepharose column described above, equilibrated with the Tris buffer containing 60 mM NaCl. The column was washed with 1.8 ml of this solution, and PG-200 was eluted with 0.4 ml of Tris buffer containing 150 mM NaCl. The chromatography was carried out in the cold room.
Preparation ofpeptide containing reductively aminated oligosaccharide
A reductive maltotriosaminalion of the peptide SISIYSYLP was performed with cyanoborohydride (Gray, 1974) . The peptide (960 p.g solubilized in DMSO) and 22 mg of maltotriose were incubated for 14 days at 38°C, in a final volume of 300 u.1 of 0.1 M phosphate buffer pH 7.5 containing 3 mg of sodium cyanoborohydride, 0.05% sodium azide, and 20% DMSO. The solution was diluted to 1.2 ml, passed through a C, 8 cartridge (O'Connell and Tabak, 1993) , and after washing with 2 ml of water, the derivatized peptide was eluted with 0.9 ml of methanol. The methanolic solution was evaporated to dryness and the residue solubilized in DMSO. For the reductive lactosamination of the nonapeptide, 15 mg of lactose replaced maltotriose in the incubation system. The procedure resulted in more than 95% conversion of nonapeptide in the N-<maltosyl-a-l-4-(I-deoxyglucitol))-and N-<l-deoxylactitol)-derivatives, as judged by ninhydrine reaction, and by TLC in propanokammonia (84:37) of samples that were labeled by radioiodination (Miozzo et aL, 1989) before chromatography.
Assay for autoglucosylaxion
The incubation mixture contained the following components, in a final volume of 15 u.1 : UDP-[ M C]glucose 28 (iM (unless otherwise indicated), 0.1 M MES pH 7.0, 5 mM MnS0 4 and 0.3-2.4 u.M glycogenin, depending on the experiment in question. Incubations were done at 30°C for the time indicated in each case. The reaction was terminated by precipitation with 200 u.1 of cold 10% (w/v) TCA after the addition of 6 uJ of 10% (w/v) bovine serum albumin. The mixture was cooled in ice for 5 min and centrifuged at 7500 x g for 3 min at 5°C. The precipitate was washed twice by centrifugation after sonication in 0.4 ml of cold 5% TCA containing 0.5% phosphotungstic acid. The washed residue was dispersed by sonication in 0.17 ml of 20% (w/v) SDS containing 0.1 M Trix, heated in a boiling bath for 3 min, mixed with scintillation solution, and counted for radioactivity in a liquid-scintillation spectrometer. The results shown are the averages of duplicates.
Assay for autoglucosylation and glucosylation of exogenous acceptors
For the simultaneous measurement of glycogenin autoglucosylation and glucosylation of exogenous acceptor, the incubation system described above was supplemented with 2.8 mM MDGP in DMSO (20% final concentration) or with DBM in the amount indicated in each case. After incubation, the mixture was diluted to 75 \il, made 1 mM in glucose and 2 mM in UDP-glucose, carrier bovine serum albumin (0.6 mg) was added, and protein was precipitated with 75 |jJ of cold 20% TCA. The TCA-insoluble residue was washed as indicated above, extracted with 0.6 ml of methanoL and counted for [ l4 C]glucose incorporated into glycogenin. The TCA-soluble fraction was passed through a C, 8 cartridge, the cartridge was washed with 1.6 ml of water, and the glucosylated exogenous acceptor eluted with 0.6 ml of methanol. The eluted fraction was mixed with the methanolic extract of the TCA-insoluble residue (see above), and counted after addition of scintillation solution. The results shown are the averages of duplicates.
The measurement of glucosyl transferase activity of proteoglycogen was carried out using DBM as described above, except that carrier albumin and TCA-precipitation were omitted.
Gel electrophoresis
Polyacrylamide gel electrophoresis in the presence of SDS was carried out as described before (Miozzo et aL, 1989) on 10% acrylamide resolving gels wim 3% stacking gels. Where indicated, 5% acrylamide was included between the resolving and stacking gels. After running, the gels were silver (Blum et aL, 1987) or Coomassie blue stained and, where indicated, subjected to autoradiography.
Other procedures
Analysis of PG-200 (100 u.1 of the solution eluted from the Q Sepharose column) by FPLC in a Superose 12 column was carried out using 50 mM Na 3 PO 4 pH 7.4 containing 0.1 M NaCl as eluent, at a flow rate of 0.3 ml/min; IgG, human serum albumin, and B-lactoglobulin were used for molecular weight calibration. Fractions of 0.3 ml were collected, cooled in ice and glucosyltransferase activity measured using DBM as acceptor (see above).
Protein was measured according to the Bradford (Bradford, 1976) or Lowry procedures (Lowry et aL, 1951) . For the quantification of glycogen the samples (up to 100 p.g of polysaccharide) were subjected to amylolysis with a-amylase (10 jj.g/ml) and amyloglucosidase (40 u,g/ml) in a final volume of 200 (rl at 37°C for 20 h. The released glucose was measured with an bexokinase/ glucose-6-phosphate dehydrogenase reagent kit
